SCHEMBL9764834

SCHEMBL9764834

CCN(Cc1ccc2c(c1)sc1ccccc12)C(=O)NO

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.47
ALDH1A1 P00352 3/20 0.47
MAPT P10636 3/20 0.47
HPGD P15428 2/20 0.47
RAB9A P51151 2/20 0.47
NPC1 O15118 1/20 0.47
GLA P06280 1/20 0.47
ALOX15 P16050 1/20 0.47
TSHR P16473 1/20 0.47
ALOX12 P18054 1/20 0.47
CD274 Q9NZQ7 1/20 0.43
HDAC1 Q13547 4/20 0.42
HDAC6 Q9UBN7 4/20 0.42
ABCC1 P33527 1/20 0.41
ABCG2 Q9UNQ0 1/20 0.41
TRPV1 Q8NER1 1/20 0.41
HDAC3 O15379 2/20 0.39
HDAC4 P56524 2/20 0.39
HDAC7 Q8WUI4 2/20 0.39
HDAC2 Q92769 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9764859 0.78 ALDH1A1 (0.39) LMNAALDH1A1MAPTHPGDRAB9A
SCHEMBL9764878 0.77 ALDH1A1 (0.39) LMNAALDH1A1MAPTHPGDRAB9A
SCHEMBL30960536 0.76 ALDH1A1 (0.44) LMNAALDH1A1MAPTHPGDRAB9A
SCHEMBL9764870 0.76 ALDH1A1 (0.38) LMNAALDH1A1MAPTHPGDRAB9A
SCHEMBL9764906 0.75 ALOX5 (0.45) LMNAALDH1A1MAPTHPGDRAB9A
SCHEMBL23874835 0.72 TSHR (0.54) LMNAALDH1A1MAPTHPGDRAB9A
SCHEMBL12436066 0.71 GPR3 (0.54) LMNAALDH1A1MAPTHPGDRAB9A
Hydroxyurea SCHEMBL9764818 0.70 MAPT (0.43) LMNAALDH1A1MAPTHPGDRAB9A
SCHEMBL11232390 0.69 AKR1B1 (0.53) LMNAALDH1A1MAPTHPGDRAB9A
SCHEMBL19429003 0.69 ALDH1A1 (0.44) LMNAALDH1A1MAPTHPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0422079-A4 TRICYCLIC LIPOXYGENASE INHIBITING COMPOUNDS, COMPOSITIONS, METHODS OF USE 1991-08-21 EP disclosed
EP-0422079-A1 TRICYCLIC LIPOXYGENASE INHIBITING COMPOUNDS, COMPOSITIONS, METHODS OF USE ABBOTT LABORATORIES (US) 1991-04-17 EP disclosed
WO-1989012636-A1 TRICYCLIC LIPOXYGENASE INHIBITING COMPOUNDS, COMPOSITIONS, METHODS OF USE ABBOTT LABORATORIES (US) 1989-12-28 WO disclosed
EP-0346939-A1 Tricyclic lipoxygenase inhibiting compounds ABBOTT LABORATORIES (US) 1989-12-20 EP disclosed
US-4822811-A Carbazole lipoxygenase inhibiting compounds, compositions and use ABBOTT LABORATORIES (US) 1989-04-18 US disclosed